Drug search by name

Ruxolitinib Phosphate and Cytopenia

Result of checking the interaction of drug Ruxolitinib Phosphate and disease Cytopenia for safety when used together.

Check result:

Ruxolitinib Phosphate <> Cytopenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of ruxolitinib can cause thrombocytopenia, anemia, and neutropenia. It is recommended to manage thrombocytopenia by reducing the dose, temporarily interrupting treatment with ruxolitinib, or as clinically appropriate. Perform a pre-treatment complete blood count (CBC) and monitor CBCs every 2 to 4 weeks until doses are stabilized, and then as clinically indicated. Close monitoring is recommended.

Ruxolitinib Phosphate

Generic Name: ruxolitinib

Brand Name: Jakafi

Synonyms: Ruxolitinib

What is Ruxolitinib Phosphate?